Phase 1 study of napabucasin, a cancer stemness inhibitor, in patients with advanced solid tumors.

MLA

Kawazoe, Akihito, et al. “Phase 1 Study of Napabucasin, a Cancer Stemness Inhibitor, in Patients with Advanced Solid Tumors.” Cancer Chemotherapy & Pharmacology, vol. 85, no. 5, May 2020, pp. 855–62. EBSCOhost, https://doi.org/10.1007/s00280-020-04059-3.

APA

Kawazoe, A., Kuboki, Y., Bando, H., Fukuoka, S., Kojima, T., Naito, Y., Iino, S., Yodo, Y., Doi, T., Shitara, K., & Yoshino, T. (2020). Phase 1 study of napabucasin, a cancer stemness inhibitor, in patients with advanced solid tumors. Cancer Chemotherapy & Pharmacology, 85(5), 855–862. https://doi.org/10.1007/s00280-020-04059-3

Chicago

Kawazoe, Akihito, Yasutoshi Kuboki, Hideaki Bando, Shota Fukuoka, Takashi Kojima, Yoichi Naito, Shuichi Iino, et al. 2020. “Phase 1 Study of Napabucasin, a Cancer Stemness Inhibitor, in Patients with Advanced Solid Tumors.” Cancer Chemotherapy & Pharmacology 85 (5): 855–62. doi:10.1007/s00280-020-04059-3.